Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by eSnowdenon May 14, 2018 9:08am

186 Views

Post# 28025688

RE:Is MPH a Pipeline company?

The pipeline is less than robust. Somehow, mph has categorized themselves as a cardiovascular co. & thus only sells cardiovascular drugs. As a result, no new drugs have been added even with a stockpile of cash. You can thank friessen for pigeon-holing the co. With a market cap below $100m, I would go after anything that can make money.

Bullboard Posts

Twelve Labs partners with AWS to revolutionize video search with AI